Ardea Revenue and Competitors
Estimated Revenue & Valuation
- Ardea's estimated annual revenue is currently $3.3M per year. 0
Employee Data
- 00
Ardea's People
Name | Title | Email/Phone |
---|
Ardea Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ardea?
IntraBiotics Pharmaceuticals, Inc., founded in 1994, is a biopharmaceutical company engaged in the development of novel antibacterial and antifungal for the treatment and prevention of serious infectious diseases, including those caused by multi-drug resistant pathogens. The Company plans to continue to build product line extensions through new formulations and new indications for its products that have progressed beyond Phase I.
keywords:N/AN/A
Total Funding
N/A
Number of Employees
$3.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ardea News
Ardea Resources Limited (OTCMKTS:ARRRF) Sees Significant Decrease in Short Interest. Posted by admin on Apr 14th, 2022.
Ardea Resources has just spiked 300% on Major Project award status for their nickel cobalt project. It might even work as they say it will...
San Diego-based Ardea Biosciences, which is developing small-molecule therapeutics for the treatment of HIV, gout, cancer and inflammatory diseases, announced Thursday that the firm has scored an $8M growth capital loan from Oxford Finance Corporation and Silicon Valley Bank. The firm said the f ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18M | 0 | N/A | $168.6M |
#2 | $8.4M | 0 | N/A | N/A |
#3 | $11.7M | 0 | N/A | $4.4M |
#4 | $36.4M | 0 | N/A | $778M |
#5 | $1.7M | 0 | N/A | N/A |